MBL deficiency-causing B allele (rs1800450) as a risk factor for severe COVID-19
Copyright © 2021 Elsevier GmbH. All rights reserved..
The COVID-19 pandemic represents one of the greatest challenges in modern medicine. The disease is characterized by a variable clinical phenotype, ranging from asymptomatic carriage to severe and/or critical disease, which bears poor prognosis and outcome because of the development of severe acute respiratory distress syndrome (SARS) requiring ICU hospitalization, multi-organ failure and death. Therefore, the determination of risk factors predisposing to disease phenotype is of outmost importance. The aim of our study was to evaluate which predisposing factors, including MBL2 genotyping, affected clinical phenotype in 264 COVID-19 patients. We demonstrated that older age along with underlying comorbidities, primarily obesity, chronic inflammatory disorders and diabetes mellitus, represent the most important risk factors related to hospitalization, the development of pneumonia and SARS. Moreover, we found that the presence of the MBL deficiency-causing B allele (rs1800450) was significantly associated with almost 2-fold increased risk for developing pneumonia and requiring hospitalization, suggesting its usage as a molecular predictor of severe disease in SARS-CoV-2 infected individuals.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:226 |
|---|---|
| Enthalten in: |
Immunobiology - 226(2021), 6 vom: 01. Nov., Seite 152136 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Speletas, Matthaios [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 06.12.2021 Date Revised 21.12.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.imbio.2021.152136 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM33169235X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM33169235X | ||
| 003 | DE-627 | ||
| 005 | 20231225214024.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.imbio.2021.152136 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1105.xml |
| 035 | |a (DE-627)NLM33169235X | ||
| 035 | |a (NLM)34628288 | ||
| 035 | |a (PII)S0171-2985(21)00084-X | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Speletas, Matthaios |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a MBL deficiency-causing B allele (rs1800450) as a risk factor for severe COVID-19 |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 06.12.2021 | ||
| 500 | |a Date Revised 21.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2021 Elsevier GmbH. All rights reserved. | ||
| 520 | |a The COVID-19 pandemic represents one of the greatest challenges in modern medicine. The disease is characterized by a variable clinical phenotype, ranging from asymptomatic carriage to severe and/or critical disease, which bears poor prognosis and outcome because of the development of severe acute respiratory distress syndrome (SARS) requiring ICU hospitalization, multi-organ failure and death. Therefore, the determination of risk factors predisposing to disease phenotype is of outmost importance. The aim of our study was to evaluate which predisposing factors, including MBL2 genotyping, affected clinical phenotype in 264 COVID-19 patients. We demonstrated that older age along with underlying comorbidities, primarily obesity, chronic inflammatory disorders and diabetes mellitus, represent the most important risk factors related to hospitalization, the development of pneumonia and SARS. Moreover, we found that the presence of the MBL deficiency-causing B allele (rs1800450) was significantly associated with almost 2-fold increased risk for developing pneumonia and requiring hospitalization, suggesting its usage as a molecular predictor of severe disease in SARS-CoV-2 infected individuals | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a MBL deficiency | |
| 650 | 4 | |a MBL2 genotyping | |
| 650 | 4 | |a Prognosis | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 7 | |a MBL2 protein, human |2 NLM | |
| 650 | 7 | |a Mannose-Binding Lectin |2 NLM | |
| 700 | 1 | |a Dadouli, Katerina |e verfasserin |4 aut | |
| 700 | 1 | |a Syrakouli, Argyro |e verfasserin |4 aut | |
| 700 | 1 | |a Gatselis, Nikolaos |e verfasserin |4 aut | |
| 700 | 1 | |a Germanidis, Georgios |e verfasserin |4 aut | |
| 700 | 1 | |a Mouchtouri, Varvara A |e verfasserin |4 aut | |
| 700 | 1 | |a Koulas, Ioannis |e verfasserin |4 aut | |
| 700 | 1 | |a Samakidou, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Nikolaidou, Anastasia |e verfasserin |4 aut | |
| 700 | 1 | |a Stefos, Aggelos |e verfasserin |4 aut | |
| 700 | 1 | |a Mimtsoudis, Iordanis |e verfasserin |4 aut | |
| 700 | 1 | |a Hatzianastasiou, Sophia |e verfasserin |4 aut | |
| 700 | 1 | |a Koureas, Michalis |e verfasserin |4 aut | |
| 700 | 1 | |a Anagnostopoulos, Lemonia |e verfasserin |4 aut | |
| 700 | 1 | |a Tseroni, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Tsinti, Gerasimina |e verfasserin |4 aut | |
| 700 | 1 | |a Metallidis, Symeon |e verfasserin |4 aut | |
| 700 | 1 | |a Dalekos, George |e verfasserin |4 aut | |
| 700 | 1 | |a Hadjichristodoulou, Christos |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Immunobiology |d 1985 |g 226(2021), 6 vom: 01. Nov., Seite 152136 |w (DE-627)NLM000456020 |x 1878-3279 |7 nnns |
| 773 | 1 | 8 | |g volume:226 |g year:2021 |g number:6 |g day:01 |g month:11 |g pages:152136 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.imbio.2021.152136 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 226 |j 2021 |e 6 |b 01 |c 11 |h 152136 | ||